68 related articles for article (PubMed ID: 24585405)
1. Profiling of autoantibodies in sera of pancreatic cancer patients.
Nagayoshi Y; Nakamura M; Matsuoka K; Ohtsuka T; Mori Y; Kono H; Aso T; Ideno N; Takahata S; Ryo A; Takeda H; Ito T; Oda Y; Endo Y; Sawasaki T; Tanaka M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S459-65. PubMed ID: 24585405
[TBL] [Abstract][Full Text] [Related]
2. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
4. Serum-autoantibodies for discovery of prostate cancer specific biomarkers.
Massoner P; Lueking A; Goehler H; Höpfner A; Kowald A; Kugler KG; Amersdorfer P; Horninger W; Bartsch G; Schulz-Knappe P; Klocker H
Prostate; 2012 Mar; 72(4):427-36. PubMed ID: 22012634
[TBL] [Abstract][Full Text] [Related]
5. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
[TBL] [Abstract][Full Text] [Related]
6. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
7. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.
Qin S; Qiu W; Ehrlich JR; Ferdinand AS; Richie JP; O'leary MP; Lee ML; Liu BC
Proteomics; 2006 May; 6(10):3199-209. PubMed ID: 16596707
[TBL] [Abstract][Full Text] [Related]
8. Profiling tumor-associated autoantibodies for the detection of colon cancer.
Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of autoantibodies in sera from patients with ovarian cancer as possible diagnostic biomarkers.
Yoneyama K; Kojima S; Kodani Y; Yamaguchi N; Igarashi A; Kurose K; Kawase R; Takeshita T; Hattori S; Nagata K
Anticancer Res; 2015 Feb; 35(2):881-9. PubMed ID: 25667470
[TBL] [Abstract][Full Text] [Related]
10. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
[TBL] [Abstract][Full Text] [Related]
11. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
Koopmann J; Rosenzweig CN; Zhang Z; Canto MI; Brown DA; Hunter M; Yeo C; Chan DW; Breit SN; Goggins M
Clin Cancer Res; 2006 Jan; 12(2):442-6. PubMed ID: 16428484
[TBL] [Abstract][Full Text] [Related]
12. Novel approach to identifying autoantibodies in rheumatoid synovitis with a biotinylated human autoantigen library and the enzyme-labeled antigen method.
Mizutani Y; Matsuoka K; Takeda H; Shiogama K; Inada K; Hayakawa K; Yamada H; Miyazaki T; Sawasaki T; Endo Y; Tsutsumi Y
J Immunol Methods; 2013 Jan; 387(1-2):57-70. PubMed ID: 23044167
[TBL] [Abstract][Full Text] [Related]
13. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study.
Bracci PM; Zhou M; Young S; Wiemels J
Cancer; 2012 Nov; 118(21):5384-94. PubMed ID: 22517435
[TBL] [Abstract][Full Text] [Related]
14. Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer.
Xia Q; Kong XT; Zhang GA; Hou XJ; Qiang H; Zhong RQ
Biochem Biophys Res Commun; 2005 May; 330(2):526-32. PubMed ID: 15796914
[TBL] [Abstract][Full Text] [Related]
15. SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma.
Sun Y; Zhang R; Wang M; Zhang Y; Qi J; Li J
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2043-7. PubMed ID: 22832207
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.
Kim S; Cho H; Nam EJ; Kim SW; Kim YT; Park YW; Kim BW; Kim JH
Genes Chromosomes Cancer; 2010 Jul; 49(7):585-95. PubMed ID: 20461751
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection.
Dumstrei K; Chen H; Brenner H
Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568
[TBL] [Abstract][Full Text] [Related]
18. Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.
Kiyamova R; Garifulin O; Gryshkova V; Kostianets O; Shyian M; Gout I; Filonenko V
Biomarkers; 2012 Jun; 17(4):362-71. PubMed ID: 22612312
[TBL] [Abstract][Full Text] [Related]
19. Detection of psoriasin/S100A7 in the sera of patients with psoriasis.
Anderson KS; Wong J; Polyak K; Aronzon D; Enerbäck C
Br J Dermatol; 2009 Feb; 160(2):325-32. PubMed ID: 19016707
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.
Bradford TJ; Wang X; Chinnaiyan AM
Urol Oncol; 2006; 24(3):237-42. PubMed ID: 16678056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
